Eurofins Scientific SE ERF
Eurofins' 800+ immaterial subsidiaries and 18 auditors enable sham sales and cash double-counting; new evidence, including a factoring denial contradicted by a former BU head, argues the financials cannot be trusted.
Thesis
In this Part II follow-up to its initial short report, Muddy Waters marshals new forensic evidence that Eurofins Scientific's balkanized structure — 1,300-1,500 legal entities, ~800-900 of them generating less than €5m of revenue, policed by at least 18 auditors with consolidation work run from India — is engineered to enable sham sales and inflated cash. The deck walks through the mechanism (invoice, related-party receivable, dividend netting, sham payable) and cites a €76.5m restatement at Eurofins Support Services Lux as evidence that large RP balances get netted routinely. It then contrasts Eurofins IR's flat denial of factoring with a former BU head's taped statement that factoring ran on both sides, and a senior tax executive's LinkedIn bio. Revenue and compensation per employee sit ~70% above Bureau Veritas, Intertek and SGS peers, and the 'no factoring' disclosure quietly vanished after 2020.
SCQA
Eurofins Scientific is a €9bn lab-testing group operating through roughly 1,300-1,500 legal entities across Europe, the US and beyond, with consolidation handled out of India and at least 18 different audit firms signing off.
That balkanized structure produces ~325,000 related-party receivables and payables per year and ~800-900 sub-€5m entities, giving management unaudited dials to fabricate revenue and classify related-party balances as Cash & Equivalents.
Investors should stop taking Eurofins' financials at face value; management's denials on factoring, audit coverage and cash classification are misleading, directly contradicted by former insiders, subsidiary filings and Bureau Veritas precedent.
No explicit price target is set; Muddy Waters discloses it is short Eurofins and expects significant gains if equity or debt prices decline once the market re-rates the quality of reported revenue and cash.
The three reasons
- 1
Eurofins has ~800-900 immaterial entities and 18 auditors, creating chaos that can hide sham sales
- 2
Management's on-record denial of factoring is contradicted by a former BU head and a senior insider's LinkedIn
- 3
Subsidiary restatements (e.g. ESS Lux €76.5m, Genomics UK -99% cash) show routine netting and unreliable reporting
Primary demands
- Do not take Eurofins' financials at face value
- Treat management's denials (factoring, audit coverage, cash classification) as unreliable
- Recognize that the balkanized entity and auditor structure enables sham revenue and cash inflation
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Precedents cited
- Bureau Veritas (peer that classifies related-party pooling as financial assets, not cash equivalents)
- Intertek and SGS (peer benchmarks on revenue and cost per employee)
Notable slides (6)
Notes
Part II follow-up to Muddy Waters' initial Eurofins short report, focused on netting/eliminations mechanics rather than a fresh thesis. Dense with French/Spanish statutory-filing screenshots. Author_name set to null because the deck is signed only by the firm. No explicit target price — standard Muddy Waters posture of short disclosure in disclaimer plus forensic argument. Dr. Martin referenced as villain but not the primary rhetorical target here; IR and the company's public rebuttal are.